Fig. 4.
In vivo NIRF imaging over time as indicated in prostate cancer. PC-3 xenograft-bearing mice at 2, 24, 48 h following i.v. injection of PEG5K-EB2 micelles co-loaded with PTX and DiD. Taken with permission from (94)
In vivo NIRF imaging over time as indicated in prostate cancer. PC-3 xenograft-bearing mice at 2, 24, 48 h following i.v. injection of PEG5K-EB2 micelles co-loaded with PTX and DiD. Taken with permission from (94)